• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

种族/民族差异对异体移植中志愿者无关供体的可及性。

Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation.

机构信息

Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY.

Department of Pediatrics, Pediatric Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY.

出版信息

Blood Adv. 2024 Jun 11;8(11):2753-2764. doi: 10.1182/bloodadvances.2023012385.

DOI:10.1182/bloodadvances.2023012385
PMID:38429097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11170144/
Abstract

Despite the global unrelated donor (URD) registry size, the degree to which URD availability is a transplant barrier is not established. We evaluated the availability of 3,843 URDs requested for 455 diverse adult patients (predominantly with acute leukemia). URDs for non-Europeans were more likely to be domestic and had markedly lower Donor Readiness scores. Of URDs requested for confirmatory HLA-typing (CT) alone (ie, without simultaneous workup), 1,894 of 3,529 (54%) were available. Availability of domestic URDs was 45%. Donor Readiness score was highly predictive of CT availability. More non-European patients (n = 120) than Europeans (n = 335) had >10 URDs requested and <5 available. Of workup requests (after CT or CT-workup), <70% (604/889 [68%]) were available. More non-Europeans had <2 URDs available. URD availability for CT was markedly worse for non-Europeans, with availabilities for African, non-Black Hispanic, and Asian patients being 150/458 (33%), 120/258 (47%), and 119/270 (44%), respectively, with further decrements in URD workup availability. Our data suggest the functional size of the URD pool is much smaller than appreciated, mandating major operational changes for transplant centers and donor registries. Likelihood of donor availability should have a high priority in donor selection. Considering patient ancestry and URD Donor Readiness scores, centers should pursue, and registries permit, simultaneous pursuit of many URDs and abandon futile searches. Patients should be informed about their likelihood of donor availability and alternative options. Finally, although registries should address high URD attrition and speed procurement, use of all HLA-disparate graft types is needed to facilitate timely transplant for all.

摘要

尽管全球有非亲属供者(URD)登记库,但 URD 可用性是否构成移植障碍尚不确定。我们评估了为 455 名不同成年患者(主要为急性白血病患者)申请的 3843 名 URD 的可用性。非欧洲裔患者的 URD 更有可能来自国内,且供者准备度评分明显较低。在仅申请确认 HLA 配型(CT)的 URD 中(即,无同时进行的检查),3529 名 URD 中的 1894 名(54%)是可用的。国内 URD 的可用性为 45%。供者准备度评分对 CT 的可用性有高度预测性。与欧洲患者(n=335)相比,有更多的非欧洲患者(n=120)申请了>10 名 URD 但仅有<5 名 URD 可用。在检查(CT 后或 CT 检查后)申请中,<70%(604/889 [68%])是可用的。非欧洲裔患者的 URD 可用性<2 名。非欧洲裔患者的 CT 用 URD 可用性明显更差,非洲、非黑西班牙裔和亚洲患者的 URD 可用性分别为 150/458(33%)、120/258(47%)和 119/270(44%),而 URD 检查可用性进一步下降。我们的数据表明,URD 库的实际规模比预期的要小得多,这需要移植中心和供者登记处进行重大运营变革。供者可用性的可能性应在供者选择中具有较高优先级。考虑到患者的祖源和 URD 供者准备度评分,中心应同时追求并允许同时追求多个 URD,并放弃无效的搜索。应告知患者其供者可用性的可能性和替代方案。最后,尽管登记处应解决 URD 大量流失和加快采购速度,但需要使用所有 HLA 不相容的移植物类型,以促进所有患者的及时移植。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6241/11170144/e40b6436c155/BLOODA_ADV-2023-012385-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6241/11170144/572506b0f6b6/BLOODA_ADV-2023-012385-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6241/11170144/56335a5b4e6c/BLOODA_ADV-2023-012385-gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6241/11170144/e40b6436c155/BLOODA_ADV-2023-012385-gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6241/11170144/572506b0f6b6/BLOODA_ADV-2023-012385-ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6241/11170144/56335a5b4e6c/BLOODA_ADV-2023-012385-gr1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6241/11170144/e40b6436c155/BLOODA_ADV-2023-012385-gr2.jpg

相似文献

1
Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation.种族/民族差异对异体移植中志愿者无关供体的可及性。
Blood Adv. 2024 Jun 11;8(11):2753-2764. doi: 10.1182/bloodadvances.2023012385.
2
Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis.种族差异对获取 HLA 匹配的非亲缘供体移植的影响:一项前瞻性的 1312 例患者分析。
Blood Adv. 2019 Apr 9;3(7):939-944. doi: 10.1182/bloodadvances.2018028662.
3
Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation.验证一种算法,以预测在搜索启动时 8/8 HLA 匹配的无关供者的可能性。
Biol Blood Marrow Transplant. 2018 May;24(5):1057-1062. doi: 10.1016/j.bbmt.2017.12.791. Epub 2017 Dec 26.
4
High-Resolution Match Rate of 7/8 and 9/10 or Better for the Be The Match Unrelated Donor Registry.“成为配型无关供者登记处”的7/8和9/10或更高分辨率匹配率
Biol Blood Marrow Transplant. 2016 Apr;22(4):759-763. doi: 10.1016/j.bbmt.2015.12.012. Epub 2015 Dec 24.
5
Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.脐带血的可用性扩大了同种异体造血干细胞移植对少数族裔的可及性。
Biol Blood Marrow Transplant. 2010 Nov;16(11):1541-8. doi: 10.1016/j.bbmt.2010.08.011. Epub 2010 Aug 25.
6
Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products.在 COVID-19 大流行期间满足非亲缘供者的需求:国家骨髓供者计划及其网络合作伙伴的快速调整确保了供者产品的安全供应。
Transplant Cell Ther. 2021 Feb;27(2):133-141. doi: 10.1016/j.jtct.2020.10.014. Epub 2020 Dec 11.
7
Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia.成人急性髓系白血病患者接受异基因移植时间差异的分析。
Blood Adv. 2023 Aug 8;7(15):3824-3833. doi: 10.1182/bloodadvances.2022008572.
8
Factors Associated with Opting Out of an Unrelated Hematopoietic Stem Cell Donor Registry: Differences and Similarities across Five Key Groups of Young Race/Ethnically Diverse Potential Donors in the United States.与选择退出无关造血干细胞捐献者登记相关的因素:美国五个关键年轻种族/族裔多样化潜在供者群体的差异和相似之处。
Transplant Cell Ther. 2024 May;30(5):512.e1-512.e15. doi: 10.1016/j.jtct.2024.02.012. Epub 2024 Feb 14.
9
Expanding donor options: haploidentical transplant recipients are also highly likely to have a 7/8-matched unrelated donor.扩大供者选择范围:单倍体相合移植受者也很有可能有一个 7/8 相合的无关供者。
Blood Adv. 2024 Feb 13;8(3):758-765. doi: 10.1182/bloodadvances.2023011814.
10
An Optimized Search Prognosis Tool to Predict 8/8 HLA Allele-Matched Unrelated Donor Procurement.优化的搜索预后工具,预测 8/8 HLA 等位基因匹配的无关供者采集。
Transplant Cell Ther. 2023 May;29(5):312.e1-312.e5. doi: 10.1016/j.jtct.2023.02.016. Epub 2023 Feb 21.

引用本文的文献

1
Characteristics and outcomes of Bahraini pediatric patients sent abroad for bone marrow transplantation: A ten-year retrospective cohort study.巴林出国进行骨髓移植的儿科患者的特征与结局:一项十年回顾性队列研究。
World J Transplant. 2025 Jun 18;15(2):100065. doi: 10.5500/wjt.v15.i2.100065.
2
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation.不匹配无关供者外周血干细胞移植后基于移植后环磷酰胺的移植物抗宿主病预防
J Clin Oncol. 2025 Jun 16:JCO2500856. doi: 10.1200/JCO-25-00856.
3
Reply to: Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor Transplantation.

本文引用的文献

1
Gender disparities in allograft access due to HLA-sensitization in multiparous women.多产妇女中因HLA致敏导致的同种异体移植物获取方面的性别差异。
Blood Adv. 2024 Jan 23;8(2):403-406. doi: 10.1182/bloodadvances.2023011893.
2
Assessing Medicaid Coverage for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy: A Project from the American Society for Transplantation and Cellular Therapy and the National Marrow Donor Program ACCESS Initiative.评估医疗补助计划对造血细胞移植和嵌合抗原受体 T 细胞疗法的覆盖范围:美国移植和细胞治疗学会与国家骨髓捐赠计划 ACCESS 倡议的项目。
Transplant Cell Ther. 2023 Nov;29(11):713-720. doi: 10.1016/j.jtct.2023.08.007. Epub 2023 Aug 12.
3
回复:基于移植后环磷酰胺的不匹配无关供体移植时代同种异体移植获取的差异
J Clin Oncol. 2025 Feb;43(4):476-478. doi: 10.1200/JCO-24-02108. Epub 2024 Nov 6.
4
Accurate analysis of race/ethnicity and socioeconomic status.对种族/族裔和社会经济地位进行准确分析。
Blood Adv. 2024 Oct 22;8(20):5433-5434. doi: 10.1182/bloodadvances.2024013917.
5
Unrelated hematopoietic stem cell donor registries: present reality and future prospects.无关造血干细胞捐献者登记:现状与未来前景。
Curr Opin Hematol. 2024 Nov 1;31(6):251-260. doi: 10.1097/MOH.0000000000000835. Epub 2024 Jul 19.
6
The American Society of Hematology Health Equity Compendium: examining health equity across the Blood journals.美国血液学会健康公平纲要:审视血液学系列期刊中的健康公平问题
Blood Adv. 2024 Sep 10;8(17):4616-4624. doi: 10.1182/bloodadvances.2024013633.
Younger Matched Unrelated Donors Confer Decreased Relapse Risk Compared to Older Sibling Donors in Older Patients with B Cell Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
在接受异基因造血细胞移植的老年 B 细胞急性淋巴细胞白血病患者中,与年长的同胞供体相比,年轻的匹配无关供体可降低复发风险。
Transplant Cell Ther. 2023 Oct;29(10):611-618. doi: 10.1016/j.jtct.2023.07.015. Epub 2023 Jul 21.
4
Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation.供者特异性 HLA 抗体与无关供者造血细胞移植后移植物失败和血液学恢复延迟有关。
Transplant Cell Ther. 2023 Aug;29(8):493.e1-493.e10. doi: 10.1016/j.jtct.2023.05.014. Epub 2023 May 21.
5
Association between non-European ancestry, low socioeconomic status, and receipt of HLA-disparate allografts in adult BMT recipients.成年骨髓移植受者中,非欧洲血统、低社会经济地位与接受人类白细胞抗原不相合同种异体移植物之间的关联。
Blood Adv. 2023 Aug 8;7(15):3834-3837. doi: 10.1182/bloodadvances.2023009955.
6
Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donors.通过与白血病护理和半相合供者整合,改善 HCT 的可及性,减少种族差异。
Blood Adv. 2023 Aug 8;7(15):3816-3823. doi: 10.1182/bloodadvances.2023009765.
7
Modeling unrelated blood stem cell donor recruitment using simulated registrant cohorts: Assessment of human leukocyte antigen matching across ethnicity groups.使用模拟注册者队列对无关血液干细胞供体招募进行建模:评估不同种族群体之间的人类白细胞抗原匹配情况。
Transfusion. 2023 May;63(5):1060-1066. doi: 10.1111/trf.17310. Epub 2023 Mar 24.
8
An Optimized Search Prognosis Tool to Predict 8/8 HLA Allele-Matched Unrelated Donor Procurement.优化的搜索预后工具,预测 8/8 HLA 等位基因匹配的无关供者采集。
Transplant Cell Ther. 2023 May;29(5):312.e1-312.e5. doi: 10.1016/j.jtct.2023.02.016. Epub 2023 Feb 21.
9
Unrelated Stem Cell Donor HLA Match Likelihood in the US Registry Incorporating HLA-DPB1 Permissive Mismatching.美国注册系统中纳入 HLA-DPB1 允许性错配的无关供者 HLA 匹配可能性。
Transplant Cell Ther. 2023 Apr;29(4):244-252. doi: 10.1016/j.jtct.2022.12.027. Epub 2023 Jan 7.
10
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial.移植后环磷酰胺在非血缘骨髓移植受者中的 3 年结果:一项全国骨髓供者计划赞助的前瞻性临床试验的随访。
Transplant Cell Ther. 2023 Mar;29(3):208.e1-208.e6. doi: 10.1016/j.jtct.2022.12.017. Epub 2022 Dec 27.